Being busy doesn't make you special, so lay off the drama
Being 'busy' is a common refrain in the workplace, with some people clutching so hard to the descriptor that it's basically part of their personality. But – and here's the harsh reality – everyone is busy. Every single one of us has too many items on our to-do list, we've all got places to go and there are dozens of open tabs in our brains that are clamouring for our attention.
Yet, some people still fall willingly into the trap of 'busyness', wearing it like a badge that sets them apart from everyone else. Every workplace has this strain of colleague who thrives on the perception they are always working too hard and are under the pump.
There's a name for this too: 'productivity theatre', which means performing actions that make you seem like you're doing things, even if it doesn't contribute meaningfully to any business outcomes.
Examples of this include attending unnecessary meetings when you don't really need to be there or spending way too much time on admin tasks instead of prioritising the important ones.
Recent research of US-based workers by software company Visier found that more than 40 per cent of employees spent more than 10 hours a week on things that could be called productivity theatre.
You're not special just because you don't know how to effectively manage your workload.
It's only too easy to get caught in the whir of being constantly busy, as it makes you feel important when everything's urgent, and you believe you're the only one who can solve it. It's also incredibly draining to feel busy all the time, and is one of the contributing factors to burnout.
So how can you escape from this cult of busyness if you find yourself getting sucked into its vortex?

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Herald Sun
an hour ago
- Herald Sun
Nick Papps appointed inaugural editor of The California Post
Don't miss out on the headlines from Victoria. Followed categories will be added to My News. Veteran News Corp Australia journalist Nick Papps has been appointed inaugural editor of The California Post – a soon-to-launch sister publication to the famed New York Post. In a statement released on Tuesday morning local time, the New York Post Media Group heralded the new media venture, with its content to appear across multiple platforms and formats, including mobile and desktop sites, video, audio, social media and a daily print edition. It will launch in early 2026. 'Now, more than ever, Californians need a media outlet dedicated to common sense, clever coverage of the most important issues, many of which are ignored or dismissed by current print and digital outlets,' the statement read. 'Despite its vibrancy – as well as the upcoming Olympic Games and World Cup – California lacks a voice that will hold leaders to account as they attempt to tackle the most critical issues facing residents. 'In fact, Los Angeles is fast becoming a news desert, despite being home to nearly 13 million monthly digital newsreaders. Thousands of stories are going untold and countless perspectives aren't being represented by a media ecosystem that has lost touch with the people – especially as the city and state face unprecedented challenges and leadership vacuums.' Papps, to be the new Los Angeles-based masthead's inaugural editor, is currently weekend editor of the Herald Sun. News Corp Australasia executive chairman Michael Miller described Papps as a 'talented' editor. 'Nick has built a great editorial career since starting out as a cadet reporter in Adelaide in 1992, and he has excelled in senior reporting and editing assignments in multiple cities,' Mr Miller said. 'Importantly for his new role, one of those cities is LA, where Nick was a correspondent for our Australian mastheads from 2004 to 2006, so he is returning to a town he knows and loves.' Herald Sun editor Sam Weir congratulated Papps. 'Nick has done a stellar job as weekend editor and played a vital role in making the Herald Sun the most-read masthead by Victorians across digital and print,' he said. 'Everyone in the newsroom wishes Nick all the success with this exciting opportunity'. News Corp chief executive Robert Thomson said the Californian market was currently 'starved' for serious reporting. 'Los Angeles and California surely need a daily dose of the Post as an antidote to the jaundiced, jaded journalism that has sadly proliferated,' Mr Thomson said. 'We are at a pivotal moment for the city and the state, and there is no doubt that the Post will play a crucial role in engaging and enlightening readers, who are starved of serious reporting and puckish wit. 'I am also pleased that (New York Post editor-in-chief) Keith Poole's remit is expanding, as he will now be responsible for covering not just New York, but California, the US, the world and, perhaps, Mars.' The California Post will operate as a separate entity under the New York Post Media Group, a subsidiary of News Corp, publisher of The Australian.


West Australian
an hour ago
- West Australian
Nexus Airlines moves to suspend Kimberley flight route from September 2025
In another blow to air services in the Kimberley, Nexus Airlines has moved to shut down its flights between Broome, Kununurra and Darwin by the end of August. The final flight from Broome to Darwin via Kununurra will depart on the morning of September 1, with Nexus Airlines to give out full refunds to all passengers booked to travel after that flight. Nexus Airlines managing director Michael McConachy cited increased competition from Airnorth, a Northern Territory‑based regional carrier owned by Bristow Helicopters Australia and a subsidiary of the US‑based Bristow Group, for the closure of the route. 'The additional capacity they introduced, and aggressive pricing have made it financially unsustainable to continue on this route and, despite Nexus taking a significant share of the market, ultimately they have deeper pockets and were prepared to continue to fly with unused capacity,' he said. 'It's a difficult business decision, especially as someone who is deeply passionate about tourism and regional growth in the Kimberley, but I remain hopeful we'll return to this route in the near future.' Mr McConachy said it was a 'disappointing' decision to make. 'I'm proud of what we've achieved. Nexus Airlines was created to improve air connectivity across regional WA,' he said. 'Having now lived in the Kimberley for nearly two decades, I witnessed firsthand how poor reliability and high fares contributed to market failure on this route, which was a key motivation in bringing Nexus Airlines to the Kimberley.' Other Nexus routes including between Perth and Geraldton, and between Geraldton, Karratha, Port Hedland and Broome continue to perform well and will remain unaffected by this network change, according to Nexus. Mr McConachy backed recent calls from the Shire of Wyndham-East Kimberley for the State Government to regulate the sector in the region. 'Regulation through a competitive tender process, where one airline is granted exclusive access to a route, can be a vital tool in protecting essential air services,' he said. 'In regions where passenger volumes are too low to support multiple operators, this approach helps ensure communities continue to benefit from dependable, affordable air travel. It's about safeguarding access to tourism, education, health care and local business. 'My hope is that the Kimberley route will be fully regulated. This would allow fares, frequency and service levels to be set and monitored by the State Government, delivering the best outcome for the towns and regions along the route.' It comes after Qantas decided to shutter Jetstar Asia in June — taking Broome's short-lived Singapore flight connection with it, which was the first international flight route for Broome International Airport in years. With the route lasting less than a year before being axed, Broome International Airport chief executive Craig Shaw described the move as 'disappointing' and a blow to the region's aspirations of boosting international tourism and business at the time.

The Australian
4 hours ago
- The Australian
Compumedics wins sales as broker lifts target ~140pc
Compumedics secures two lucrative sales for its Somfit sleep device with combined revenues approaching $2 million Sales to a leading CRO in US and a Finnish pharmaceutical company support strategy to expand in adjacent markets East Coast Research revises Compumedics target price to 75 cents per share, showing upside potential of 138.7% Special Report: Compumedics has secured lucrative multiple Somfit sales to leading pharmaceutical and clinical research organisations (CROs) in the US and Europe East Coast Research sees an almost 140% upside to its current target price. Compumedics (ASX: CMP), a global medical device company specialising in sleep, brain and ultrasonic blood flow monitoring, has inked a sale with a leading CRO for its Somfit devices. The company noted the devices will be used in a major US-based clinical drug trial with one of the world's largest pharmaceutical companies. Compumedics also secured a second sale with Finland-based global pharmaceutical firm Orion Pharma for deployment of Somfit devices across a multi-country, multi-centre clinical study in Europe. Somfit is a wearable device used for collecting physiological data during sleep with combined revenues from both sales approaching $2 million. The sales support the company's strategy to expand into adjacent markets, where Somfit's ability to collect electroencephalography (EEG) signals and provide insights into sleep stages and patterns provides a distinct advantage over traditional home sleep testing systems. The contracts also validate Somfit's clinical value proposition in the pharmaceutical sector, where understanding the effects of new drugs on sleep is becoming an increasingly important regulatory and research requirement. 'Building a diversified global business' Executive chairman and CEO Dr David Burton said the sales wins highlight the growing momentum Compumedics was seeing for Somfit in new market segments. 'The pharmaceutical clinical trial market is an ideal adjacency for our technology, and these early contracts, approaching $2 million in combined value, demonstrate Somfit's versatility beyond traditional home sleep testing,' 'This is another important step in building a diversified global business with multiple high growth pathways." Compumedics expects to build on this early traction, continuing engagement with major pharmaceutical companies and research institutions worldwide. Broker re-rates Compumedics following milestones and global expansion Meanwhile, East Coast Research has revised its target price for Compumedics to 75 cents per share, representing an upside potential of 138.7% from the share price at the time of its review and an 11.9% increase on its previous 67 cent target set in March. In its updated valuation, East Coast Research set a base case of 59 cents per share and an upside case of 92 cents, with a price-to-NAV (net asset value) of 0.42x. The Sydney-based equity research house said the re-rating reflected several key achievements, including: Record FY25 sales orders of $63.4m, up 22% YoY and return to profitability with $3m EBITDA for the financial year Validation of its world-first dual-use Orion LifeSpan MEG system Strong FY26 guidance with $70m in revenue and $9m in EBITDA supported by US launch of Somfit D, rising SaaS contributions and delivery of three MEG systems A $24.4 million pipeline secured through two long-term distribution agreements in China Broader entry into pharmaceutical trials 'These developments not only strengthen CMP's position in high-growth segments like SaaS and brain imaging but also significantly de-risk its revenue outlook and enhance its value proposition in the global medtech and connected health markets,' the broker noted. East Coast said Compumedics remained well-positioned for long-term value creation. This article was developed in collaboration with Compumedics, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.